Compound, method for producing said compound, curable material, curable composition, method for producing cured product, and cured product
By using a curable composition with double curing of light and thermal curing in the smartphone camera module, the existing adhesive sags during insufficient light and thermal curing are solved, and the effect of high-intensity, low-temperature and short-term curing is achieved. Suitable for bonding needs of thin equipment.
Patent Information
- Application Number
- CN202380033081.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-09-27
- Filing Date
- 2023-09-21
- Publication Date
- 2024-11-19
AI Technical Summary
During the bonding process of the existing adhesives, there are problems such as insufficient light resulting in incomplete curing, temperature rise during thermal curing, and viscosity reduction and sagging, which is difficult to meet the needs of high-intensity, low-temperature and short-term curing.
Provided is a curable composition that is double cured by light and heat, including compounds of specific structures (such as general formula (1) and general formula (2)) and curing agent, which are thermally formally cured after photoprecuring, and use reactions The esterification of the unsaturated bonds and epoxy groups ensures sufficient curability.
It realizes sufficient curing under light and thermal conditions, improves bonding strength and stability, avoids insufficient light and sag problems during thermal curing, and is suitable for camera module bonding for thin devices such as smartphones.
Smart Images

Figure CN118984828A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a compound, and more particularly to a compound having a reactive unsaturated bond and an epoxy group, and further to a curable composition containing at least one of the compound and at least one selected from a curing agent and a polymerization initiator. Background Art
[0002] In recent years, as portable devices such as smartphones have become thinner, camera modules installed in portable devices such as smartphones have become smaller. As camera modules become smaller, the locations where components of camera modules are joined together have also become smaller, so the adhesive layer formed by the adhesive joining them together is required to have a high adhesive strength.
[0003] In addition, the adhesive used in the assembly of camera modules, etc., is required to have low-temperature curing properties in order to avoid thermal damage to image sensors, etc. caused by high-temperature treatment. In addition, from the perspective of improving production efficiency, short-time curing properties are also required. From this perspective, many ultraviolet curing adhesives or thermosetting epoxy resin adhesives are used as low-temperature and short-time curing adhesives. However, ultraviolet curing adhesives can cure quickly, but on the other hand, they have disadvantages such as being unable to be used for bonding parts that are not exposed to light. On the other hand, even if thermosetting epoxy resin adhesives are low-temperature and short-time curing adhesives, the bonded components (parts) must be fixed with a clamp or device in order to maintain the bonding posture during bonding. In addition, the viscosity decreases due to the temperature rise caused by heating, resulting in sagging before curing, or flowing to other than the desired part, which may not be satisfactory.
[0004] In order to solve the above-mentioned problems, an adhesive of the type that is temporarily fixed by curing (pre-curing) by light irradiation and further cured (formal curing) by heat for bonding has been proposed. For example, Patent Document 1 proposes a light and heat curable composition, which contains a curable component composed of a compound having a glycidyl group and a (meth)acryloyl group, a polythiol compound, and an epoxy curing accelerator. Patent Document 2 proposes a curable composition, which contains a compound having a (meth)acryloyl group, a polythiol compound, a photoradical generator, a latent curing agent, and also describes a compound having a (meth)acryloyl group and an epoxy group.
[0005] However, the epoxy (meth)acrylates described in Patent Documents 1 and 2 merely describe compounds obtained by esterifying a part of the epoxy groups by reacting an epoxy resin having two or more epoxy groups with (meth)acrylic acid, and their structures are limited.
[0006] Furthermore, Patent Document 3 proposes a compound having a (meth)acryloyl group and a glycidyl group, but it is not a compound having sufficient curability as a material used in a curing system utilizing light and heat.
[0007] Prior art literature
[0008] Patent Literature
[0009] Patent Document 1: Japanese Patent Application Publication No. 2009-51954
[0010] Patent Document 2: WO2018 / 181421A1
[0011] Patent document 3: US20200048301A1 Summary of the invention
[0012] Problems to be solved by the invention
[0013] Therefore, an object of the present invention is to provide a compound that can be used in a curable composition that can be cured by light and heat, and further to provide a curable composition that is excellent in curability by light and heat.
[0014] Means for solving problems
[0015] That is, the present invention provides a compound represented by the following general formula (1).
[0016] [Chemical formula 1]
[0017]
[0018] In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 3 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group, a methylglycidyl ether group, an acryloyloxymethyl group or a methacryloyloxymethyl group, and R 4 represents a hydrogen atom or a methyl group. n represents a number of 0 to 4.
[0019] Furthermore, the present invention provides a compound represented by the following general formula (2).
[0020] [Chemical formula 2]
[0021]
[0022] In the formula, R 1 represents a hydrogen atom or a methyl group, R2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 5 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methylglycidyl ether group. n represents a number of 0 to 4.
[0023] In addition, a method for producing a compound represented by formula (1) is provided, characterized in that a compound represented by the following formula (3) is reacted with an epihalohydrin to produce a compound represented by formula (2), and the compound is esterified with an acrylate and / or a methacrylate.
[0024] [Chemical formula 3]
[0025]
[0026] In the formula, R 2 Each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent. 6 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or a hydroxymethyl group. n represents a number of 0 to 4.
[0027] In addition, the present invention provides a curable material comprising: a compound represented by formula (1), and
[0028] At least one of the compound represented by the formula (2) and the compound represented by the following general formula (4).
[0029] [Chemical formula 3A]
[0030]
[0031] In the formula, R 7 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms, a hydroxyl group or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a hydroxyl group or a halogen atom as a substituent, and R 8 R represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxyalkyl group, a glycidyl ether group, a methylglycidyl ether group, a glycidyloxyalkyl group, a β-methylglycidyloxyalkyl group, an acryloyloxyalkyl group or a methacryloyloxyalkyl group. 9 represents a hydrogen atom or a methyl group. m represents a number of 0-4.
[0032] The present invention also provides a curable composition comprising (A) at least one of the compounds represented by the general formula (1) and (B) at least one selected from a curing agent, a cured product of the composition, and a method for producing the cured product having a curing step of curing the composition.
[0033] Effects of the Invention
[0034] The compound provided by the present invention is suitable as a material that is cured by light and heat. The curable composition provided by the present invention has sufficient photocurability and excellent thermosetting property, so it can be suitably used for dual curing by temporary curing by light and then formally curing by heat.
[0035] Furthermore, according to the production method of the present invention, a compound suitable for a curing material using light and heat can be produced by an industrially advantageous method. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 These are the measurement results of DMA of the resin composition obtained in Example 3.
[0037] Figure 2 These are the measurement results of DMA of the resin composition obtained in Example 6. DETAILED DESCRIPTION
[0038] A. Compounds
[0039] Hereinafter, the compound of the present invention will be described in detail.
[0040] The compound represented by the general formula (1) of the present invention (hereinafter also referred to as "compound (1)" or "component (A)") has a glycidyl ether group and a reactive unsaturated bond as described above, and therefore can provide a cured product by light and / or heat by using it in combination with various curing agents and various polymerization initiators. It should be noted that the reactive unsaturated bond is sometimes also referred to as an "ethylenically unsaturated bond".
[0041] In the above general formula (1), R 2 Examples of the alkyl group having 1 to 20 carbon atoms include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, tert-pentyl, hexyl, heptyl, octyl, 2-ethylhexyl, nonyl, isononyl, decyl, isodecyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, benzyl, and phenethyl.
[0042] In the above general formula (1), R 2Examples of the alkoxy group having 1 to 20 carbon atoms include methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy and decyloxy.
[0043] In the above general formula (1), R 2 Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
[0044] In the above general formula (1), R 2 Examples of the unsubstituted aryl group in the aryl group which may have a substituent include phenyl and naphthyl. Examples of the substituent include alkyl groups having 1 to 10 carbon atoms such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, tert-pentyl, hexyl, heptyl, octyl, 2-ethylhexyl, nonyl, isononyl, and decyl; alkoxy groups having 1 to 10 carbon atoms such as methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, and decyloxy; and halogen atoms such as fluorine, chlorine, bromine, and iodine.
[0045] In the above general formula (1), n is preferably an integer of 0 to 2, and compounds in which n is 0 or 1 are more preferred because of their excellent curability by light and heat and the ease of obtaining raw materials. 2 Compounds that are alkyl or methoxy groups having 1 to 4 carbon atoms are more preferred because they have excellent curing properties by light and heat and are easy to obtain raw materials. Among them, in the general formula (1), preferably n is 0 or 1, and R 2 The compound is an alkyl group having 1 to 4 carbon atoms or a methoxy group, and n is preferably 0.
[0046] In the above general formula (1), R 3 Examples of the alkyl group having 1 to 10 carbon atoms include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, tert-pentyl, hexyl, heptyl, octyl, 2-ethylhexyl, nonyl, isononyl, and decyl.
[0047] R 3 It is preferably an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl group or a methylglycidyl group. Among them, an alkyl group having 1 to 10 carbon atoms is preferred, and an alkyl group having 1 to 5 carbon atoms is particularly preferred, among which a methyl group or an ethyl group is particularly preferred, and an ethyl group is most preferred. 3 The above-mentioned groups make it easy to obtain raw materials and facilitate curing by light and heat at low cost.
[0048] As R 4, preferably a hydrogen atom from the viewpoint of excellent photocurability. 4 It is methyl.
[0049] As R 1 In terms of excellent thermosetting properties, hydrogen atoms are preferred. In terms of excellent stability and physical properties of the cured product, R 1 It is methyl.
[0050] The compound (1) is a compound represented by any of the following general formulas (1a), (1b) or (1c), but these compounds may be present as a mixture.
[0051] For example, the compound represented by formula (1a) is preferred because of its good photocurability. In addition, the compound represented by (1b) or (1c), especially (1c), is preferred because of its high heat resistance of the photo- and heat-cured product and its difficulty in crystallization.
[0052] [Chemical formula 4]
[0053]
[0054] [Chemical formula 5]
[0055]
[0056] [Chemical formula 6]
[0057]
[0058] It should be noted that R in the compounds represented by the above general formulas (1a), (1b) and (1c) 1 , R 2 , R 3 , R 4 And n can be exemplified by those shown in the above formula (1).
[0059] Specific examples of the compounds represented by the above-mentioned general formulas (1a), (1b) and (1c) are listed below.
[0060] [Chemical formula 7]
[0061]
[0062] [Chemical formula 8]
[0063]
[0064] [Chemical formula 9]
[0065]
[0066] [Chemical formula 10]
[0067]
[0068] [Chemical formula 11]
[0069]
[0070] [Chemical formula 12]
[0071]
[0072] [Chemical formula 13]
[0073]
[0074] [Chemical formula 14]
[0075]
[0076] [Chemical formula 15]
[0077]
[0078] [Chemical formula 16]
[0079]
[0080] [Chemical formula 17]
[0081]
[0082] [Chemical formula 18]
[0083]
[0084] The total chlorine content of the compound (1) of the present invention and a mixture thereof is preferably 3000 ppm or less by mass. When the total chlorine content exceeds 3000 ppm, the material has a high concentration of chloride ions and is prone to ion migration. For example, when used as an adhesive or sealant for electrical / electronic components, the reliability may be reduced. In addition, the titanium atom content is preferably 7000 ppm or less by mass. If the titanium atom content exceeds 7000 ppm, the free radical polymerizability may be reduced. The total chlorine content is measured based on ASTM D5808. In addition, the titanium atom content can be measured based on JIS K0116:2014.
[0085] In the compound represented by the general formula (2) (hereinafter also referred to as "compound (2)"), R 1 , R 2Examples and preferred examples of n include the following: 1 , R 2 and n are the contents exemplified above and their preferred contents. 5 The alkyl group having 1 to 20 carbon atoms represented by is exemplified by the following: 3 As R 5 The group represented by is preferably an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methyl glycidyl ether group. Among them, an alkyl group having 1 to 10 carbon atoms is preferred, an alkyl group having 1 to 5 carbon atoms is more preferred, a methyl group or an ethyl group is further preferred, and an ethyl group is particularly preferred. 5 The above-mentioned group makes it easy to obtain the raw material and to easily provide a compound suitable for a curable composition utilizing light and heat.
[0086] The R of the compound (2) used as a raw material of the compound (1) is 5 Preferably, R 3 In addition, in the curable material and curable composition described below, when compound (1) and compound (2) are present together, R 3 With compound (2) R 5 It can be the same or different.
[0087] The compound represented by the general formula (2) can be used in various applications because it has both an alcoholic hydroxyl group and a glycidyl group. In addition, the compound represented by the general formula (2) is useful as a raw material for the compound represented by the general formula (1) in the present invention.
[0088] The compound represented by the general formula (2) is a compound represented by any one of the following general formulas (2a), (2b) or (2c), but they may also exist as a mixture. The compounds represented by formula (2a), (2b) or (2c) are raw materials for the compounds represented by formula (1a), (1b) or (1c), respectively. In the case where compound (1) and compound (2) coexist in the curable material and curable composition described later, it is preferred that the compound represented by formula (1a), (1b) or (1c) coexists with the compound (2) (respectively represented by formula (2a), (2b) or (2c)) as its raw material, but it is not limited to this scheme.
[0089] [Chemical formula 19]
[0090]
[0091] [Chemical formula 20]
[0092]
[0093] [Chemical formula 21]
[0094]
[0095] It should be noted that R in the compounds represented by the above general formulae (2a), (2b) and (2c) 1 , R 2 , R 5 And n is the same as in the above formula (2).
[0096] Specific examples of the compounds represented by the above-mentioned general formulae (2a), (2b) and (2c) are listed below.
[0097] [Chemical formula 22]
[0098]
[0099] [Chemical formula 23]
[0100]
[0101] [Chemical formula 24]
[0102]
[0103] [Chemical formula 25]
[0104]
[0105] [Chemical formula 26]
[0106]
[0107] [Chemical formula 27]
[0108]
[0109] The total chlorine content of the compound (2) of the present invention and its mixture is preferably 3000 ppm or less by mass. When the total chlorine content exceeds 3000 ppm, the concentration of chloride ions is high and ion migration is easily induced. For example, when used as an adhesive or sealant for electrical / electronic components, the reliability may be reduced. In addition, the titanium atom content is preferably 7000 ppm or less by mass. If the titanium atom content exceeds 7000 ppm, the free radical polymerizability may be reduced.
[0110] The method for producing the compound (1) of the present invention is not particularly limited, but the compound (2) can be produced by glycidyl etherifying only the phenolic hydroxyl group and the alcoholic hydroxyl group in the compound containing at least two hydroxyl groups represented by the following general formula (3), and then the alcoholic hydroxyl group of the compound (2) is esterified with acrylic acid or methacrylic acid. The prior art such as patent documents 1 and 2 is a technology that esterifies a part of the epoxy groups in the epoxy resin containing two or more epoxy groups with acrylic acid. This method has the problem of difficulty in controlling the composition of the reaction product, the tendency that the unreacted epoxy resin tends to remain relatively much during the production and the viscosity tends to increase, etc., and is not satisfactory for the curing system using light and heat in consideration of the refining cost. In contrast, with respect to the present method, since the above-mentioned difference in reactivity can be utilized, the composition of the reaction product can be easily controlled, the refining cost can be reduced, and a curable material suitable for the curing system using light and heat can be provided at a low cost.
[0111] More specifically, in the present invention, compound (1) can be produced, for example, by the production method described below.
[0112] The method for producing compound (2) of the present invention is carried out by glycidyl etherifying only the phenolic hydroxyl group by utilizing the difference in reactivity between the phenolic hydroxyl group and the alcoholic hydroxyl group in the compound represented by the following general formula (3) (hereinafter also referred to as "compound (3)").
[0113] [Chemical formula 28]
[0114]
[0115] (Where R 2 Each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group which may have a substituent, or a halogen atom. The substituent is a group selected from an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, or a halogen atom. 6 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or a hydroxymethyl group. n represents a number from 0 to 4.
[0116] As R in compound (3) 2 Examples of n and their preferred contents include the following: 2 and n are exemplified and preferably described. In addition, as R in compound (3), 6 The alkyl group having 1 to 20 carbon atoms represented by is exemplified by the following: 3 As R 6The group represented by is preferably an alkyl group having 1 to 10 carbon atoms or a hydroxymethyl group. 5 For the same reasons as described above, an alkyl group having 1 to 10 carbon atoms is preferred, an alkyl group having 1 to 5 carbon atoms is more preferred, a methyl group or an ethyl group is further preferred, and an ethyl group is particularly preferred. R of the compound (3) used as a raw material for the compound (2) 6 Preferably, R 5 same.
[0117] As a method for glycidyl etherifying the phenolic hydroxyl group in the compound represented by the general formula (3), there can be mentioned a method of adding a base to a mixture of the compound represented by the general formula (3) and an epihalohydrin to react. As a method for adding the base, there can be mentioned a method of dripping an aqueous base solution and a method of adding a solid base preferably in multiple portions.
[0118] Examples of the epihalohydrin include epichlorohydrin, epibromohydrin, and β-methylepichlorohydrin.
[0119] Examples of the base include metal hydroxides such as sodium hydroxide, potassium hydroxide, and calcium hydroxide.
[0120] When the compound represented by the general formula (3) is reacted with epihalohydrin, the amount of epihalohydrin used is preferably 3 to 50 times, more preferably 4 to 30 times, the amount of the compound represented by the general formula (3) in terms of molar ratio.
[0121] The amount of the base used is preferably in the range of 0.8 to 1.5 mol, more preferably 0.9 to 1.2 mol, based on 1 mol of the compound represented by the general formula (3).
[0122] It is not necessary to use a phase transfer catalyst such as tetrabutylammonium bromide in the reaction between the compound represented by the general formula (3) and epihalohydrin. In this specification, not using a phase transfer catalyst in the reaction between the compound represented by the general formula (3) and epihalohydrin means that the mass of the phase transfer catalyst is less than one hundredth of the mass of the compound represented by the general formula (3).
[0123] The reaction of the compound represented by the general formula (3) and the epihalohydrin is carried out under heating or under pressure or under reduced pressure as necessary.
[0124] The reaction temperature is not particularly limited, but is preferably 40° C. or higher and 120° C. or lower, and more preferably 60° C. or higher and 100° C. or lower, from the viewpoint of shortening the production time and reaction efficiency.
[0125] Examples of a method for producing the compound represented by the general formula (1) by subjecting the compound represented by the general formula (2) to acrylic acid esterification or methacrylic acid esterification include a method of esterification using an acrylic acid derivative and / or a methacrylic acid derivative.
[0126] Specifically, there are methods of esterifying using acrylic acid esters such as methyl acrylate and / or methacrylic acid esters such as methyl methacrylate in the presence of a catalyst such as dialkyltin oxide or tetraalkyl titanate, and methods of esterifying using acrylic acid chloride and / or methacrylic acid chloride in the presence of a neutralizing agent such as triethylamine.
[0127] In the former case where esterification is carried out using an acrylic acid ester and / or a methacrylic acid ester in the presence of a catalyst, the reaction temperature is preferably, for example, 50 to 100° C., and more preferably 70 to 90° C., from the perspective of shortening the production time and reaction efficiency. In the latter case where esterification is carried out using an acrylic acid chloride and / or a methacrylic acid chloride in the presence of a neutralizing agent, the reaction temperature is preferably, for example, 0 to 30° C., from the perspective of shortening the production time and reaction efficiency.
[0128] In particular, a method using an acrylate and / or a methacrylate is preferred from the viewpoint of safety and reaction efficiency, particularly the ability to suppress side reactions.
[0129] The amount of acrylic acid derivatives and / or methacrylic acid derivatives used is preferably 2 times or more, more preferably 3 times or more, based on the molar ratio of the compound represented by the above general formula (2). In addition, from the perspective of production efficiency, the amount of acrylic acid derivatives and / or methacrylic acid derivatives used is preferably 10 times or less, more preferably 7 times or less, based on the molar ratio of the compound represented by the above general formula (2).
[0130] B. Curable Materials
[0131] Next, the curable material of the present disclosure will be described.
[0132] One of the characteristics of the curable material disclosed herein is that it contains the compound represented by the above-mentioned formula (1) (hereinafter also referred to as "compound (1)").
[0133] As a preferred embodiment of the present disclosure, there can be mentioned a curable material containing the above-mentioned compound (1) and at least one selected from the group consisting of compound (2) and a compound represented by the above-mentioned general formula (4) (hereinafter also referred to as "compound (4)". In particular, from the perspective of reducing the production cost and obtaining the above-mentioned effects, it is preferred that compounds (2) and (4) are impurities when compound (1) is produced by the above-mentioned preferred production method.
[0134] As R 7The alkyl group having 1 to 20 carbon atoms, the alkoxy group having 1 to 20 carbon atoms, the aryl group having 5 to 10 carbon atoms which may have a substituent, and the halogen atom represented by the formula (1) may be any of the following: 2 The alkyl group having 1 to 20 carbon atoms, the alkoxy group having 1 to 20 carbon atoms, the aryl group having 5 to 10 carbon atoms which may have a substituent, and the halogen atom represented are the same groups.
[0135] For R 7 The substituents of the aryl group having 5 to 10 carbon atoms which may be substituted are alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and halogen atoms, and the like may also be exemplified as R in formula (1). 2 The substituents of the aryl group having 5 to 10 carbon atoms which may be substituted are the same as those exemplified above.
[0136] In addition, as R 7 Preferred examples of the group represented by include 2 Preferred examples are the same groups.
[0137] The preferred numerical range of m is the same as that of n. 9 A preferred example is the same as the above R 1 same.
[0138] As R 8 The hydroxyalkyl group in the above-mentioned group includes a hydroxymethyl group, a hydroxyethyl group, a hydroxypropyl group and the like.
[0139] Examples of the glycidyloxyalkyl group include a glycidyloxymethyl group and a glycidyloxyethyl group.
[0140] Examples of the acryloyloxyalkyl group include an acryloyloxymethyl group and an acryloyloxyethyl group.
[0141] Examples of the methacryloyloxyalkyl group include a methacryloyloxymethyl group and a methacryloyloxyethyl group.
[0142] As R 8 , preferably an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methyl glycidyl ether group, among which an alkyl group having 1 to 10 carbon atoms is preferred, an alkyl group having 1 to 5 carbon atoms is more preferred, a methyl group or an ethyl group is particularly preferred, and an ethyl group is most preferred.
[0143] The R of the compound (4) generated as an impurity 7 ,m,R 8 and R 9 Preferably, R 2 ,n,R 3and R 1 When compound (1) and compound (4) coexist in the curable material or curable composition described below, R of compound (4) 7 ,m,R 8 and R 9 and R of compound (1) 2 ,n,R 3 and R 1 They may be the same or any one of them may be different.
[0144] The compound represented by the general formula (4) is a compound represented by any one of the following general formulas (4a), (4b) or (4c), but these compounds may be present as a mixture.
[0145] The compound represented by formula (4a), (4b) or (4c) is an impurity of the compound represented by formula (1a), (1b) or (1c). When compound (1) and compound (4) coexist in the curable material and curable composition described later, it is preferred that the compound represented by formula (1a), (1b) or (1c) coexists with the corresponding compound (4) (compound represented by formula (4a), (4b) or (4c) respectively), but the present invention is not limited thereto.
[0146] [Chemical formula 29]
[0147]
[0148] [Chemical formula 30]
[0149]
[0150] [Chemical formula 31]
[0151]
[0152] It should be noted that R in the compounds represented by the above general formulae (4a), (4b) and (4c) 1 , R 2 , R 5 And n is the same as in the above formula (4).
[0153] Specific examples of the compounds represented by the above-mentioned general formulae (4a), (4b) and (4c) are listed below.
[0154] [Chemical formula 32]
[0155]
[0156] [Chemical formula 33]
[0157]
[0158] [Chemical formula 34]
[0159]
[0160] [Chemical formula 35]
[0161]
[0162] [Chemical formula 36]
[0163]
[0164] [Chemical formula 37]
[0165]
[0166] [Chemical formula 38]
[0167]
[0168] [Chemical formula 39]
[0169]
[0170] [Chemical formula 40]
[0171]
[0172] From the viewpoint of heat resistance of a cured product obtained after curing, the curable material of the present disclosure preferably contains the compound (4) among the compound (2) and the compound (4).
[0173] In the present disclosure, in the curable material containing compound (1) and at least one selected from compound (2) and compound (4), the ratio of compound (1) in the total of compound (1), compound (2) and compound (4) is preferably 80% by mass or more, more preferably 90% by mass or more, and particularly preferably 95% by mass or more. Because by being the lower limit, the light and thermosetting effects brought by the compound of formula (1) are excellent. As the upper limit of the ratio of compound (1), in the total of compound (1), compound (2) and compound (4), it is preferably 100% by mass, but in the case of containing compound (2) and / or compound (4), it is preferably 99.5% by mass or less, and more preferably 98% by mass or less from the aspects of reducing manufacturing costs.
[0174] In addition, in the above-mentioned curable material, the proportion of compound (2) in the total of compound (1), compound (2) and compound (4) is preferably 15% by mass or less, more preferably 10% by mass or less, and particularly preferably 6% by mass or less. This is because ensuring the content of the compound of formula (1) has excellent effects of good light and heat curing properties. In the case of containing compound (2), its amount is preferably 0.1% by mass or more, and more preferably 0.5% by mass or more in the total of compound (1), compound (2) and compound (4) from the perspective of manufacturing cost, heat resistance, etc.
[0175] Furthermore, in the above-mentioned curable material, the proportion of compound (4) in the total of compound (1), compound (2) and compound (4) is preferably 15% by mass or less, more preferably 10% by mass or less, and particularly preferably 5% by mass or less. This is because by keeping the proportion of compound (4) below this value, the content of the compound of formula (1) is ensured, and the effect of good light and heat curing properties is excellent. When compound (4) is contained, its amount is preferably 0.1% by mass or more, and more preferably 0.5% by mass or more, from the perspective of manufacturing cost, heat resistance, etc.
[0176] C. Curable Composition
[0177] Next, the curable composition of the present invention will be described in detail.
[0178] The curable composition of the present invention comprises (A) at least one of the compounds represented by the general formula (1) (hereinafter also referred to as "component (A)") and (B) a curing agent (hereinafter also referred to as "component (B)"). As component (A), only compound (1) may be used, or, for example, the above-mentioned curable materials may be used.
[0179] The curable composition of the present invention may contain compounds other than the above-mentioned component (A) each having one or more reactive unsaturated bonds and epoxy groups. Examples of such compounds include glycidyl methacrylate, glycidyl ether of allylphenol, diglycidyl monoallyl ether, epoxy acrylates, and the like. 8 In the case of an acryloyloxyalkyl group or a methacryloyloxyalkyl group, the compound (4) can also be mentioned.
[0180] Furthermore, the curable composition of the present invention may contain a compound having only a reactive unsaturated bond and an epoxy group among epoxy groups, or a compound having only a reactive unsaturated bond.
[0181] Examples of the above-mentioned compound having only an epoxy group include compound (2) and compound (4) (R 8 is other than an acryloyloxyalkyl group or a methacryloyloxyalkyl group).
[0182] In addition, for example, well-known epoxy resins can be cited. Examples of the epoxy resins include polyglycidyl ether compounds of mononuclear polyphenol compounds such as hydroquinone, resorcinol, pyrocatechol, and phloroglucinol; dihydroxynaphthalene, biphenol, methylene bisphenol (bisphenol F), methylene bis (o-cresol), ethylene bisphenol, isopropylidene bisphenol (bisphenol A), isopropylidene bis (o-cresol), tetrabromobisphenol A, 1,3-bis (4-hydroxycumylbenzene), 1,4-bis (4-hydroxycumylbenzene), 1,1,3-tri (4-hydroxyphenyl) butane, 1,1,2,2-tetra ... (4-hydroxyphenyl)ethane, thiobisphenol, sulfonylbisphenol, oxybisphenol (oxybisphenol), phenol novolac, o-cresol novolac, ethylphenol novolac, butylphenol novolac, octylphenol novolac, resorcinol novolac, terpene phenol and other polynuclear polyphenol compounds of glycidyl ether compounds; ethylene glycol, propylene glycol, butanediol, hexanediol, polyethylene glycol, thiodiglycol, glycerol, trimethylolpropane, pentaerythritol, sorbitol, bisphenol Polyglycidyl ethers of polyols such as A-alkylene oxide adducts, dicyclopentadiene dimethanol diglycidyl ether, etc.; glycidyl esters of aliphatic, aromatic or alicyclic polyacids such as maleic acid, fumaric acid, itaconic acid, succinic acid, glutaric acid, suberic acid, adipic acid, azelaic acid, sebacic acid, dimer acid, trimer acid, phthalic acid, isophthalic acid, terephthalic acid, trimellitic acid, trimesic acid, pyromellitic acid, tetrahydrophthalic acid, hexahydrophthalic acid, and endomethylenetetrahydrophthalic acid; glycidyl methacrylate Homopolymers or copolymers of oil esters; epoxides of cyclic olefin compounds such as vinyl cyclohexene diepoxide, dicyclopentadiene diepoxide, 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, 3,4-epoxy-6-methylcyclohexylmethyl-6-methylcyclohexanecarboxylate, and bis(3,4-epoxy-6-methylcyclohexylmethyl) adipate; epoxidized conjugated diene polymers such as epoxidized polybutadiene and epoxidized styrene-butadiene copolymers, and heterocyclic compounds such as triglycidyl isocyanurate. In addition, these epoxy resins may be epoxy resins formed by internal crosslinking of terminal isocyanate prepolymers, or epoxy resins formed by increasing the molecular weight using polyvalent active hydrogen compounds (polyphenols, polyamines, carbonyl-containing compounds, polyphosphates, etc.).
[0183] Examples of commercially available products of the epoxy resin include DENACOL EX-313, DENACOL EX-314, DENACOL EX-321, DENACOL EX-411, DENACOL EX-421, DENACOL EX-512, DENACOL EX-521, DENACOL EX-611, DENACOL EX-612, DENACOL EX-614, DENACOL EX-622, DENACOL EX-830, DENACOL EX-832, DENACOL EX-841, DENACOL EX-861, DENACOL EX-920, DENACOL EX-931, DENACOL EX-201, DENACOL EX-711, and DENACOL EX-721 (manufactured by Nagase ChemteX Co., Ltd.); EPOLIGHT 200E, EPOLIGHT 400E, and EPOLIGHT 70P, EPOLIGHT 200P, EPOLIGHT 400P (manufactured by Kyoeisha Chemical Co., Ltd.), ADEKA RESIN EP-4088S, EP-4088L, EP-4080E, ADEKA RESIN EP-4000, ADEKA RESIN EP-4005, ADEKA RESIN EP-4100, ADEKA RESIN EP-4901 (manufactured by ADEKA Corporation); OGSOL PG-100, OGSOL EG-200, OGSOL EG-210, OGSOL EG-250 (manufactured by Osaka Gas Chemicals); YD series, YDF series, YDPN series, TDCN series (manufactured by Nippon Steel & Sumitomo Metal Chemicals); CELLOXIDE 2021P, CELLOXIDE 2081 (manufactured by Daicel Corporation); TECHMORE VG-3101L (manufactured by Printec); EOCN-1020, EOCN-102S, EOCN-103S, EOCN-104S, XD-1000, NC-3000, EPPN-501H, EPPN-501HY, EPPN-502H, NC-7000L (manufactured by Nippon Kayaku Co., Ltd.); YX8800 (manufactured by Mitsubishi Chemical); HP4032, HP4032D, HP4700 (manufactured by DIC Corporation), etc.
[0184] Examples of the compound having only reactive unsaturated bonds include (meth)acrylamide derivatives containing N-alkyl groups such as N-methyl (meth)acrylamide, N,N-dimethyl (meth)acrylamide, N,N-diethyl (meth)acrylamide, N-isopropyl (meth)acrylamide, N-butyl (meth)acrylamide, and N-hexyl (meth)acrylamide; (meth)acrylamide derivatives containing N-alkoxy groups such as N-hydroxymethyl (meth)acrylamide, N-hydroxyethyl (meth)acrylamide, N-hydroxymethyl-N-propane (meth)acrylamide, N-methoxymethylacrylamide, and N-ethoxymethylacrylamide; (meth)acrylamide derivatives such as N-acryloylmorpholine, N-acryloylpiperidine, N-methacryloylpiperidine, and N-acryloylpyrrolidine; and (meth)acrylamide derivatives such as ethylene, propylene, butylene, isopropyl (meth)acrylamide, N-butyl (meth)acrylamide, and N-hexyl (meth)acrylamide. Unsaturated aliphatic hydrocarbons such as butene, vinyl chloride, vinylidene chloride, vinylidene fluoride, and tetrafluoroethylene; mono(meth)acrylates of polymers having carboxyl groups and hydroxyl groups at both ends such as (meth)acrylic acid, α-chloroacrylic acid, itaconic acid, maleic acid, citraconic acid, fumaric acid, nadic acid (himic acid), crotonic acid, isocrotonic acid, vinylacetic acid, allylacetic acid, cinnamic acid, sorbic acid, mesaconic acid, succinic acid mono[2-(meth)acryloyloxyethyl], phthalic acid mono[2-(meth)acryloyloxyethyl], and ω-carboxypolycaprolactone mono(meth)acrylate; unsaturated polybasic acids such as (meth)acrylic acid·hydroxyethyl maleate, (meth)acrylic acid·hydroxypropyl maleate, dicyclopentadiene·maleate, or polyfunctional (meth)acrylates having one carboxyl group and two or more (meth)acryloyl groups;2-Hydroxyethyl (meth)acrylate, 2-Hydroxypropyl (meth)acrylate, methyl (meth)acrylate, butyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, cyclohexyl (meth)acrylate, n-octyl (meth)acrylate, isooctyl (meth)acrylate, isononyl (meth)acrylate, stearyl (meth)acrylate, lauryl (meth)acrylate, methoxyethyl (meth)acrylate, dimethylaminomethyl (meth)acrylate, dimethylaminoethyl (meth)acrylate, aminopropyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, ethoxyethyl (meth)acrylate, poly(ethoxy)ethyl (meth)acrylate , butoxyethoxyethyl (meth)acrylate, ethylhexyl (meth)acrylate, phenoxyethyl (meth)acrylate, tetrahydrofuranyl (meth)acrylate, vinyl (meth)acrylate, allyl (meth)acrylate, benzyl (meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, trimethylolethane tri(meth)acrylate, trimethylolpropane tri(meth)acrylate, dipentaerythritol hexa(meth)propylene Esters of unsaturated monobasic acids and polyols or polyphenols such as acrylates, dipentaerythritol penta(meth)acrylate, pentaerythritol tetra(meth)acrylate, pentaerythritol tri(meth)acrylate, tricyclodecane dihydroxymethyl di(meth)acrylate, tri[(meth)acryloylethyl]isocyanurate, polyester (meth)acrylate oligomers; metal salts of unsaturated polybasic acids such as zinc (meth)acrylate and magnesium (meth)acrylate; unsaturated aldehydes such as acrolein; unsaturated nitriles such as (meth)acrylonitrile, α-chloroacrylonitrile, vinylidene cyanide, and allyl cyanide; styrene, 4-methylstyrene, 4-ethylstyrene, 4-methoxystyrene, 4-hydroxystyrene, 4-chlorostyrene, divinylbenzene, ethylene Unsaturated aromatic compounds such as methyl toluene, vinyl benzoic acid, vinyl phenol, vinyl sulfonic acid, 4-vinylbenzenesulfonic acid, vinyl benzyl methyl ether, vinyl benzyl glycidyl ether; unsaturated ketones such as methyl vinyl ketone; unsaturated amine compounds such as vinylamine, allylamine, N-vinyl pyrrolidone, vinyl piperidine; vinyl alcohols such as allyl alcohol and crotyl alcohol; vinyl ethers such as vinyl methyl ether, vinyl ethyl ether, n-butyl vinyl ether, isobutyl vinyl ether, allyl glycidyl ether; unsaturated imides such as maleimide, N-phenylmaleimide, N-cyclohexylmaleimide; indene such as indene and 1-methylindene; aliphatic conjugated dienes such as 1,3-butadiene, isoprene, chloroprene;Macromonomers having a mono(meth)acryloyl group at the end of the polymer molecular chain, such as polystyrene, poly(methyl)acrylate, poly(butyl)acrylate, and polysiloxane; vinyl chloride, vinylidene chloride, divinyl succinate, diallyl phthalate, triallyl phosphate, triallyl isocyanurate, vinyl sulfide, vinyl imidazole, vinyl oxazoline, vinyl carbazole, vinyl pyrrolidone, vinyl pyridine, vinyl monomers containing hydroxyl groups and vinyl carbamate compounds of polyisocyanate compounds, vinyl monomers containing hydroxyl groups and vinyl epoxy compounds of polyepoxide compounds. ;
[0185] From the aspects of the curability of the curable composition, it is preferred that the amount of the (A) component (compound (1)) in the curable composition of the present invention is 30% by mass or more and 99% by mass or less, more preferably 50% by mass or more and 97% by mass or less. In addition, the total amount of the compound including the compound other than the (A) component and the (A) component, the compound having an epoxy group and / or a reactive unsaturated bond in the curable composition can also be 30% by mass or more and 99% by mass or less, or 50% by mass or more and 97% by mass or less. In the case where the curable composition also contains other compounds having an epoxy group and / or a reactive unsaturated bond in addition to the (A) component, it is considered from the aspects of curability that the amount of the other compounds is preferably 100% by mass or less relative to 100% by mass of the (A) component, more preferably 70% by mass or less.
[0186] Preferred examples of the curing agent as the component (B) used in the curable resin composition of the present invention include amine curing agents, phenol curing agents, acid anhydride curing agents, polythiol curing agents, and polymerization initiators.
[0187] Examples of the amine curing agent include alkylenediamines such as ethylenediamine, 1,2-diaminopropane, 1,3-diaminopropane, 1,3-diaminobutane, 1,4-diaminobutane, and hexamethylenediamine; polyalkylpolyamines such as diethylenetriamine, triethylenetriamine, and tetraethylenepentamine; 1,4-diaminocyclohexane, 1,3-diaminocyclohexane, 1,3-diaminomethylcyclohexane, 1,2-diaminocyclohexane, 1,4- Alicyclic polyamines such as diamino-3,6-diethylcyclohexane, 4,4'-diaminodicyclohexylmethane, 1,3-bis(aminomethyl)cyclohexane, 1,4-bis(aminomethyl)cyclohexane, 4,4'-diaminodicyclohexylpropane, bis(4-aminocyclohexyl)sulfone, 4,4'-diaminodicyclohexyl ether, 2,2'-dimethyl-4,4'-diaminodicyclohexylmethane, isophoronediamine, norbornene diamine, etc.; meta-xylylenediamine , diaminodiphenylmethane, diaminodiphenyl sulfone, diethyltoluenediamine, 1-methyl-3,5-diethyl-2,4-diaminobenzene, 1-methyl-3,5-diethyl-2,6-diaminobenzene, 1,3,5-triethyl-2,6-diaminobenzene, 3,3'-diethyl-4,4'-diaminodiphenylmethane, 3,5,3', 5'-tetramethyl-4,4'-diaminodiphenylmethane and other aromatic polyamines; benzoguanamine, acetyl Guanamines such as guanamine; imidazoles such as 2-methylimidazole, 2-ethyl-4-methylimidazole, 2-isopropylimidazole, 2-undecylimidazole, 2-heptadecylimidazole, 2-phenylimidazole, 2-phenyl-4-methylimidazole, and 2-aminopropylimidazole; dihydrazides such as oxalic acid dihydrazide, malonic acid dihydrazide, succinic acid dihydrazide, glutaric acid dihydrazide, adipic acid dihydrazide, suberic acid dihydrazide, azelaic acid dihydrazide, sebacic acid dihydrazide, and phthalic acid dihydrazide;N,N-dimethylaminoethylamine, N,N-diethylaminoethylamine, N,N-diisopropylaminoethylamine, N,N-diallylaminoethylamine, N,N-benzylmethylaminoethylamine, N,N-dibenzylaminoethylamine, N,N-cyclohexylmethylaminoethylamine, N,N-dicyclohexylaminoethylamine, N-(2-aminoethyl)pyrrolidine, N-(2-aminoethyl)piperidine, N-(2-aminoethyl)morpholine, N-(2-aminoethyl)piperazine, N-(2-aminoethyl)-N'-methylpiperazine, N, N-dimethylaminopropylamine, N,N-diethylaminopropylamine, N,N-diisopropylaminopropylamine, N,N-diallylaminopropylamine, N,N-benzylmethylaminopropylamine, N,N-dibenzylaminopropylamine, N,N-cyclohexylmethylaminopropylamine, N,N-dicyclohexylaminopropylamine, N-(3-aminopropyl)pyrrolidine, N-(3-aminopropyl)piperidine, N-(3-aminopropyl)morpholine, N-(3-aminopropyl)piperazine, N-(3-aminopropyl)-N'-methylpiperidine, 4-(N ,N-dimethylamino)benzylamine, 4-(N,N-diethylamino)benzylamine, 4-(N,N-diisopropylamino)benzylamine, N,N,-dimethylisophoronediamine, N,N-dimethylbisaminocyclohexane, N,N,N'-trimethylethylenediamine, N'-ethyl-N,N-dimethylethylenediamine, N'-ethyl-N,N-dimethylpropanediamine, N'-ethyl-N,N-dibenzylaminopropylamine; N,N-(bisaminopropyl)-N-methylamine, N,N-bisaminopropylethylamine, N,N-bisaminopropyl N,N-bisaminopropylbutylamine, N,N-bisaminopropylpentylamine, N,N-bisaminopropylhexylamine, N,N-bisaminopropyl-2-ethylhexylamine, N,N-bisaminopropylcyclohexylamine, N,N-bisaminopropylbenzylamine, N,N-bisaminopropylallylamine, bis〔3-(N,N-dimethylaminopropyl)〕amine, bis〔3-(N,N-diethylaminopropyl)〕amine, bis〔3-(N,N-diisopropylaminopropyl)〕amine, bis〔3-(N,N-dibutylaminopropyl)〕amine, etc. ;
[0188] In addition, the above-mentioned amine curing agent can also be an amine latent curing agent obtained by various modifications. As modified amines, for example, dehydrated condensates of the above-mentioned amine compounds and carboxylic acids, adducts of the above-mentioned amine compounds and epoxy compounds (compounds exemplified as the above-mentioned epoxy resins), adducts of the above-mentioned amine compounds and isocyanate compounds (isocyanate compounds exemplified below), Michael adducts of amine compounds, Mannich reaction products of amine compounds, condensates of amine compounds and urea, condensates of amine compounds and ketones, and the like can be cited. In addition, for example, dibasic acid dihydrazides such as oxalic acid dihydrazide, malonic acid dihydrazide, succinic acid dihydrazide, glutaric acid dihydrazide, adipic acid dihydrazide, suberic acid dihydrazide, azelaic acid dihydrazide, sebacic acid dihydrazide, and phthalic acid dihydrazide; guanamines such as benzoguanamine and acetylguanamine; dicyandiamide; melamine, etc. can also be used as amine latent curing agents.
[0189] Examples of the isocyanate compound include aromatic diisocyanates such as 2,4-tolylene diisocyanate, 2,6-tolylene diisocyanate, diphenylmethane-4,4′-diisocyanate, phenylene diisocyanate, xylylene diisocyanate, tetramethylxylylene diisocyanate, 1,5-naphthalene diisocyanate, 1,5-tetrahydronaphthalene diisocyanate, 3,3′-dimethyldiphenyl-4,4′-diisocyanate, dianisidine diisocyanate, and tetramethylxylylene diisocyanate; aromatic diisocyanates such as isophorone diisocyanate, dicyclohexylmethane-4,4′-diisocyanate, and tetramethylxylylene diisocyanate; alicyclic diisocyanates such as isocyanate, trans-1,4-cyclohexyl diisocyanate, norbornene diisocyanate; aliphatic diisocyanates such as tetramethylene diisocyanate, 1,6-hexamethylene diisocyanate, 2,2,4 and / or (2,4,4)-trimethylhexamethylene diisocyanate, lysine diisocyanate; isocyanurate trimers, biuret trimers, trimethylolpropane adducts of the above-mentioned diisocyanates; triphenylmethane triisocyanate, 1-methylbenzene-2,4,6-triisocyanate, dimethyltriphenylmethane tetraisocyanate, etc.
[0190] Furthermore, these isocyanate compounds may be used in a carbodiimide-modified, isocyanurate-modified, biuret-modified or other form, or may be used in a blocked isocyanate form blocked with various blocking agents.
[0191] Examples of the phenolic curing agent include phenol novolac resins, cresol novolac resins, aromatic hydrocarbon formaldehyde resin-modified phenolic resins, dicyclopentadiene phenol addition type resins, phenol aralkyl resins (Xyloc resins), naphthol aralkyl resins, trisphenol methane resins, tetraphenol ethane resins, naphthol novolac resins, naphthol-phenol co-condensation novolac resins, naphthol-cresol co-condensation novolac resins, biphenyl-modified phenolic resins (polyphenolic compounds in which phenol nuclei are linked by dimethylene groups), biphenyl-modified naphthol resins (polyphenolic naphthol compounds in which phenol nuclei are linked by dimethylene groups), aminotriazine-modified phenolic resins (compounds having a phenol skeleton, a triazine ring and a primary amino group in the molecular structure), and alkoxy-containing aromatic ring-modified novolac resins (polyphenolic compounds in which a phenol nucleus and an alkoxy-containing aromatic ring are linked by formaldehyde).
[0192] Examples of the acid anhydride curing agent include nadic anhydride, phthalic anhydride, maleic anhydride, methylnadic anhydride, succinic anhydride, tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methyltetrahydrophthalic anhydride, methylhexahydrophthalic anhydride, trialkyltetrahydrophthalic anhydride-maleic anhydride adduct, benzophenonetetracarboxylic anhydride, trimellitic anhydride, pyromellitic anhydride, and hydrogenated methylnadic anhydride.
[0193] Examples of the polythiol curing agent include pentaerythritol tetrakis (3-mercaptopropionate), pentaerythritol tetrakis (thioglycolate), dipentaerythritol hexakis (3-mercaptopropionate), dipentaerythritol hexakis (3-mercaptobutyrate), 1,3,4,6-tetrakis (2-mercaptoethyl)-1,3,4,6-tetraazaoctahydropentalene-2,5-dione, 1,3,5-tris (3-mercaptopropyl)-1,3,5-triazine-2,4,6 (1H, 3H, 5H)-trione, 4-mercaptomethyl-1,8-dimercapto-3,6-dithiaoctane, 4,8-, 4,7- or 5,7-dimercaptomethyl-1,11-dimercapto-3,6,9-trithiaundecane, and 1,3,4,6-tetrakis (2-mercaptoethyl) glycoluril. , 1,2,3-tris(mercaptomethylthio)propane, 1,2,3-tris(2-mercaptoethylthio)propane, 1,2,3-tris(3-mercaptopropylthio)propane, 4-mercaptomethyl-1,8-dimercapto-3,6-dithiaoctane, 5,7-dimercaptomethyl-1,11-dimercapto-3,6,9-trithiaundecane, 4,7-dimercaptomethyl-1,11-dimercapto-3,6,9-trithiaundecane, 4,8-dimercaptomethyl-1,11-dimercapto-3,6,9-trithiaundecane, tetrakis(mercaptomethylthiomethyl)methane, tetrakis(2-mercaptoethylthiomethyl)methane, tetrakis(3-mercaptopropylthiomethyl)methane, 1,1,3,3-tetrakis(mercaptomethylthio)propane, 1,1, 2,2-Tetrakis(mercaptomethylthio)ethane, 4,6-bis(mercaptomethylthio)-1,3-dithiane, 1,1,5,5-tetrakis(mercaptomethylthio)-3-thiapentane, 1,1,6,6-tetrakis(mercaptomethylthio)-3,4-dithiahexane, 2,2-bis(mercaptomethylthio)ethanethiol, 3-mercaptomethylthio-1,7-dimercapto-2,6-dithiaheptane, 3,6-bis(mercaptomethylthio)-1,9-dimercapto-2,5,8-trithianonane, 3-mercaptomethylthio-1,6-dimercapto-2,5-dithiahexane, 1,1,9,9-tetrakis(mercaptomethylthio)-5-(3,3-bis(mercaptomethylthio)-1-thiapropyl)3,7-dithianonane, trithia (2,2-bis(mercaptomethylthio)ethyl)methane, tris(4,4-bis(mercaptomethylthio)-2-thiabutyl)methane, tetrakis(2,2-bis(mercaptomethylthio)ethyl)methane, tetrakis(4,4-bis(mercaptomethylthio)-2-thiabutyl)methane, 3,5,9,11-tetrakis(mercaptomethylthio)-1,13-dimercapto-2,6,8,12-tetrathiatridecane, 3,5,9,11,15,17-hexa(mercaptomethylthio)-1,19-dimercapto-2,6,8,12,14,18-hexathianonadecane, 9-(2,2-bis(mercaptomethylthio)ethyl)-3,5,13,15-tetrakis(mercaptomethylthio)-1,17-dimercapto-2,6,8,10,12,16-hexathiaheptadecane, 3,4,8,9-tetrakis(mercaptomethylthio)-1,11-dimercapto-2,5,7,10-tetrathiaundecane, 3,4,8,9,13,14-hexa(mercaptomethylthio)-1,16-dimercapto-2,5,7,10,12,15-hexathiahexadecane, 8-[bis(mercaptomethylthio)methyl]-3,4,12,13-tetrakis(mercaptomethylthio)-1,15-dimercapto-2,5,7,9,11,14-hexathiapentadecane, 4,6-bis[3,5-bis(mercaptomethylthio)-7-mercapto-2,6-dithiaheptylthio]-1,3-dithiane, 4-[3,5-bis(mercaptomethylthio)-7-mercapto-2,6- dithiaheptylthio]-6-mercaptomethylthio-1,3-dithiane, 1,1-bis[4-(6-mercaptomethylthio)-1,3-dithianylthio]-1,3-bis(mercaptomethylthio)propane, 1-[4-(6-mercaptomethylthio)-1,3-dithianylthio]-3-[2,2-bis(mercaptomethylthio)ethyl]-7,9-bis(mercaptomethylthio)-2,4,6,10-tetrathiaundecane, 1,5-bis[4-(6-mercaptomethylthio)-1,3-dithianylthio]-3-[2-(1,3-dithianyl)]methyl-2,4-dithiapentane, 3-[2-(1,3-dithianyl)]methyl-7,9-bis(mercaptomethylthio)- 1,11-dimercapto-2,4,6,10-tetrathiaundecane, 9-[2-(1,3-dithietanyl)]methyl-3,5,13,15-tetrakis(mercaptomethylthio)-1,17-dimercapto-2,6,8,10,12,16-hexathiaheptadecane, 3-[2-(1,3-dithietanyl)]methyl-7,9,13,15-tetrakis(mercaptomethylthio)-1,17-dimercapto-2,4,6,10,12,16-hexathiaheptadecane, 3,7-bis[2-(1,3-dithietanyl)]methyl-1,9-dimercapto-2,4,6,8-tetrathianonane, 4,6-bis{3-[2-(1,3-dithietanyl)]methyl-5-mercapto 4-[3,4,8,9-tetrakis(mercaptomethylthio)-11-mercapto-2,5,7,10-tetrathiaundecyl]-5-mercaptomethylthio-1,3-dithiolane, 4,5-bis[3,4-bis(mercaptomethylthio)-6-mercapto-2,5-dithiahexylthio]-1,3-dithiolane, 4-[3,4-bis(mercaptomethylthio)-6-mercapto-2,5-dithiahexylthio]-5-mercaptomethylthio-1,3-dithiolane3-dithiolane, 4-[3-bis(mercaptomethylthio)methyl-5,6-bis(mercaptomethylthio)-8-mercapto-2,4,7-trithiooctyl]-5-mercaptomethylthio-1,3-dithiolane, 2-{bis[3,4-bis(mercaptomethylthio)-6-mercapto-2,5-dithiahexylthio]methyl}-1,3-dithiolane, 2-[3,4-bis(mercaptomethylthio)methyl-5,6-bis(mercaptomethylthio)-8-mercapto-2,4,7-trithiooctyl]-5-mercaptomethylthio-1,3-dithiolane )-6-mercapto-2,5-dithiahexylthio]mercaptomethylthiomethyl-1,3-dithiacyclobutane, 2-[3,4,8,9-tetrakis(mercaptomethylthio)-11-mercapto-2,5,7,10-tetrathiaundecylthio]mercaptomethylthiomethyl-1,3-dithiacyclobutane, 2-[3-bis(mercaptomethylthio)methyl-5,6-bis(mercaptomethylthio)-8-mercapto-2,4, 7-trithiooctyl]mercaptomethylthiomethyl-1,3-dithioethane, 4,5-bis{1-[2-(1,3-dithioethane)]-3-mercapto-2-thiopropylthio}-1,3-dithioethane, 4-{1-[2-(1,3-dithioethane)]-3-mercapto-2-thiopropylthio}-5-[1,2-bis(mercaptomethylthio)-4-mercapto-3-thioethane butylthio]-1,3-dithiolane, 2-{bis[4-(5-mercaptomethylthio-1,3-dithiolanyl)thio]methyl}-1,3-dithiolane, 4-[4-(5-mercaptomethylthio-1,3-dithiolanyl)thio]-5-{1-[2-(1,3-dithiolanyl)]-3-mercapto-2-thiapropylthio}-1,3-dithiolane, etc.
[0194] In particular, the use of a tetravalent or higher-valent polythiol compound is preferred because a curable composition having excellent curability can be obtained.
[0195] The above-mentioned amine curing agents, phenol curing agents, acid anhydride curing agents, and polythiol curing agents are known as curing agents for epoxy resins. Examples of commercially available products thereof include Adeka Hardener EH-3636S (manufactured by ADEKA Corporation; dicyandiamide type latent curing agent), Adeka Hardener EH-4351S (manufactured by ADEKA Corporation; dicyandiamide type latent curing agent), Adeka Hardener EH-5011S (manufactured by ADEKA Corporation; imidazole type latent curing agent), Adeka Hardener EH-5046S (manufactured by ADEKA Corporation; imidazole type latent curing agent), Adeka Hardener EH-4357S (manufactured by ADEKA Corporation; polyamine type latent curing agent), Adeka Hardener EH-5057P (manufactured by ADEKA Corporation; polyamine type latent curing agent), and Adeka Hardener EH-5057PK (manufactured by ADEKA Co., Ltd.; polyamine type latent curing agent), Amicure PN-23 (manufactured by Ajinomoto Finetechno Co., Ltd.; amine addition type latent curing agent), Amicure PN-40 (manufactured by Ajinomoto Finetechno Co., Ltd.; amine addition type latent curing agent), Amicure VDH (manufactured by Ajinomoto Finetechno Co., Ltd.; hydrazide type latent curing agent), Fujicure FXR-1020 (manufactured by T&K TOKA Co., Ltd.; latent curing agent), TS-G manufactured by Shikoku Chemical Industry Co., Ltd., DPMP and PEMP manufactured by SC Organic Chemical Co., Ltd., PETG manufactured by Yodo Chemical Co., Ltd., etc.
[0196] The amount of the epoxy resin curing agent (a curing agent selected from the above-mentioned amine curing agent, phenol curing agent, anhydride curing agent and polythiol curing agent) used is not particularly limited, but is preferably 100 parts by mass or less, more preferably 2 to 50 parts by mass, relative to 100 parts by mass of component (A). In the case of containing component (A) and other compounds having an epoxy group and / or a reactive unsaturated bond, it is preferably 100 parts by mass or less, more preferably 2 to 50 parts by mass, relative to 100 parts by mass of the total of the other compounds and component (A).
[0197] In addition, in the curable composition of the present invention, a curing catalyst may be used together with the above-mentioned epoxy resin curing agent. Examples of the curing catalyst include phosphine compounds such as triphenylphosphine; phosphonium salts such as tetraphenylphosphonium bromide; amines such as benzyldimethylamine and 2,4,6-tris(dimethylaminomethyl)phenol; quaternary ammonium salts such as trimethylammonium chloride; ureas such as 3-(p-chlorophenyl)-1,1-dimethylurea, 3-(3,4-dichlorophenyl)-1,1-dimethylurea, 3-phenyl-1,1-dimethylurea, isophorone diisocyanate-dimethylurea, and tolylene diisocyanate-dimethylurea; and complexes of boron trifluoride and tertiary amines or ether compounds. These curing catalysts may be used alone or in combination of two or more.
[0198] The amount of the curing catalyst used in the curable composition of the present invention is preferably 0.01 to 20 parts by mass relative to 100 parts by mass of the component (A). In the case of containing the component (A) and other compounds having an epoxy group and / or a reactive unsaturated bond, it is preferably 0.01 to 20 parts by mass relative to 100 parts by mass of the total of the other compounds and the component (A).
[0199] Examples of the polymerization initiator include a thermal radical polymerization initiator, a photoradical polymerization initiator, and a cationic polymerization initiator.
[0200] Examples of the polymerization initiator include a thermal radical polymerization initiator, a photoradical polymerization initiator, and a cationic polymerization initiator.
[0201] The thermal radical polymerization initiator is not particularly limited as long as it generates radicals by heating, and conventionally known compounds can be used. For example, azo compounds, peroxides, and persulfates are preferred.
[0202] Examples of the azo compound include 2,2′-azobisisobutyronitrile, 2,2′-azobis(methyl isobutyrate), 2,2′-azobis-2,4-dimethylvaleronitrile, and 1,1′-azobis(1-acetoxy-1-phenylethane).
[0203] Examples of the peroxide include benzoyl peroxide, di-tert-butylbenzoyl peroxide, tert-butyl peroxypivalate, and di(4-tert-butylcyclohexyl)peroxydicarbonate.
[0204] Examples of the persulfate include persulfates such as ammonium persulfate, sodium persulfate, and potassium persulfate.
[0205] The photoradical polymerization initiator is not particularly limited as long as it is a substance that generates radicals by light irradiation, and conventionally known compounds can be used. For example, acetophenone compounds, benzyl compounds, benzophenone compounds, thioxanthone compounds and oxime ester compounds can be exemplified as preferred examples.
[0206] Examples of the acetophenone compounds include diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropane-1-one, 4'-isopropyl-2-hydroxy-2-methylpropiophenone, 2-hydroxymethyl-2-methylpropiophenone, 2,2-dimethoxy-1,2-diphenylethane-1-one, p-dimethylaminoacetophenone, p-tert-butyldichloroacetophenone, p-tert-butyltrichloroacetophenone, p-azidobenzylideneacetophenone, 1-hydroxy Cyclohexyl phenyl ketone, 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropanone-1, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone-1, benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin n-butyl ether, benzoin isobutyl ether and 1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one, etc.
[0207] As said benzyl type compound, benzil etc. are mentioned, for example.
[0208] Examples of the benzophenone-based compound include benzophenone, methyl o-benzoylbenzoate, Michler's ketone, 4,4′-bisdiethylaminobenzophenone, 4,4′-dichlorobenzophenone, and 4-benzoyl-4′-methyldiphenyl sulfide.
[0209] Examples of the thioxanthone-based compound include thioxanthone, 2-methylthioxanthone, 2-ethylthioxanthone, 2-chlorothioxanthone, 2-isopropylthioxanthone, and 2,4-diethylthioxanthone.
[0210] The oxime ester compound is a compound having an oxime ester group, and among the photoradical polymerization initiators, it can be preferably used in the curable composition of the present invention from the viewpoint of good sensitivity.
[0211] Among the above-mentioned oxime ester compounds, compounds having a carbazole skeleton, a diphenyl sulfide skeleton, or a fluorene skeleton are more preferably used in the curable composition of the present invention because they have particularly high sensitivity.
[0212] Examples of other radical polymerization initiators include phosphine oxide compounds such as 2,4,6-trimethylbenzoyldiphenylphosphine oxide and titanocene compounds such as bis(cyclopentadienyl)-bis[2,6-difluoro-3-(pyrrol-1-yl)]titanium and the like.
[0213] Examples of commercially available radical polymerization initiators include ADEKA OPTOMER N-1414, N-1717, N-1919, ADEKA ARKLS NCI-831, NCI-930 (all manufactured by ADEKA); IRGACURE 184, IRGACURE 369, IRGACURE 651, IRGACURE 907, IRGACURE OXE 01, IRGACURE OXE 02, IRGACURE 784 (all manufactured by BASF); TR-PBG-304, TR-PBG-305, TR-PBG-309, and TR-PBG-314 (all manufactured by Tronly); and the like.
[0214] The cationic polymerization initiator can be any cationic polymerization initiator as long as it is a compound that can release a substance that initiates cationic polymerization by irradiation with energy rays or heating, and is preferably an onium salt, i.e., a double salt, or a derivative thereof that releases a Lewis acid by irradiation with energy rays. As a representative example of the compound, salts of cations and anions represented by the following general formula can be cited.
[0215] [A] r+ [B] r-
[0216] Among them, the cation [A] r+ Onium is preferred, and its structure can be represented by the following general formula, for example.
[0217] [(R 12 ) a Q] r+
[0218] Furthermore, among them, R 12 is an organic group having 1 to 60 carbon atoms and may contain several atoms other than carbon atoms. a is an integer of 1 to 5. 12 are independent of each other and may be the same or different. In addition, at least one of them is preferably an organic group as described above having an aromatic ring. Q is an atom or an atomic group selected from the group consisting of S, N, Se, Te, P, As, Sb, Bi, O, I, Br, Cl, F, and N=N. In addition, when the cation [A] r+ When the atomic valence of Q in is set to q, the relationship r=aq must hold (wherein N=N is treated as an atomic valence of 0).
[0219] In addition, the anion [B] r- A halide complex is preferred, and its structure can be represented by the following general formula, for example.
[0220] [LY b ] r-
[0221] Here, L is a metal or semimetal (metalloid) as the central atom of the halide complex, such as B, P, As, Sb, Fe, Sn, Bi, Al, Ca, In, Ti, Zn, Sc, V, Cr, Mn, Co, etc. Y is a halogen atom. b is an integer of 3 to 7. In addition, when the anion [B] r- When the atomic valence of L in is set to p, the relationship r=bp must hold.
[0222] As the anion of the above general formula [LY b ] r- Specific examples include tetrakis(pentafluorophenyl)borate, tetrakis(3,5-difluoro-4-methoxyphenyl)borate, tetrafluoroborate (BF4) - 、Hexafluorophosphate (PF6) - 、Hexafluoroantimonate (SbF6) - 、Hexafluoroarsenate (AsF6) - 、Hexachloroantimonate (SbCl6) - wait.
[0223] In addition, the anion [B] r- Anions having a structure represented by the following general formula can also be preferably used: L, Y, and b are the same as those described above.
[0224] [LY b-1 (OH)] r
[0225] In addition, as other anions that can be used, perchlorate ion (ClO4) can be listed. - , trifluoromethylsulfite ion (CF3SO3) - 、Fluorosulfonate ion (FSO3) - , toluenesulfonate anion, trinitrobenzenesulfonate anion, camphorsulfonate, nonafluorobutanesulfonate, hexafluorooctanesulfonate, tetraarylborate, tetrakis(pentafluorophenyl)borate, etc.
[0226] In the present invention, among such onium salts, the following aromatic onium salts (1) to (3) are particularly effective. These may be used alone or in combination of two or more.
[0227] (1) Aryl diazonium salts such as phenyldiazonium hexafluorophosphate, 4-methoxyphenyldiazonium hexafluoroantimonate, and 4-methylphenyldiazonium hexafluorophosphate
[0228] (2) Diphenyliodonium hexafluoroantimonate, di(4-methylphenyl)iodonium hexafluorophosphate, di(4-tert-butylphenyl)iodonium hexafluorophosphate, tolylcumyliodonium tetrakis(pentafluorophenyl)borate and other diaryliodonium salts
[0229] (3) Sulfonium salts of sulfonium cations represented by the following Group I or Group II and hexafluoroantimony ions, hexafluorophosphate ions, tetrakis(pentafluorophenyl)borate ions, etc.
[0230] [Chemical formula 41]
[0231] <Group I>
[0232]
[0233] [Chemical formula 42]
[0234] <Group II>
[0235]
[0236] The amount of the polymerization initiator in the curing agent composition of the present invention is preferably 0.001 to 20 parts by mass relative to 100 parts by mass of the component (A). In the case of containing the component (A) and other compounds having an epoxy group and / or a reactive unsaturated bond, the amount of the polymerization initiator can be set to 0.001 to 20 parts by mass relative to 100 parts by mass of the total of the other compounds and the component (A). By setting it to 20 parts by mass or less, the influence on the water absorption rate of the cured product, the strength of the cured product and other physical properties can be suppressed.
[0237] When the curable composition of the present invention is photocured using a polymerization initiator, a sensitizer and a sensitizing aid may be used. Examples of the sensitizer and the sensitizing aid include anthracene compounds, naphthalene compounds, and the like.
[0238] Examples of the anthracene compounds include 9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 9,10-dipropoxyanthracene, 9,10-diisopropoxyanthracene, 9,10-dibutoxyanthracene, 9,10-dipentyloxyanthracene, 9,10-dihexyloxyanthracene, 9,10-bis(2-methoxyethoxy)anthracene, 9,10-bis(2-ethoxyethoxy)anthracene, 9,10-bis(2-butoxyethoxy)anthracene, 9,10-bis(3-butoxypropoxy)anthracene, and 9,10-bis(2-methoxyethoxy)anthracene. oxy)anthracene, 2-methyl- or 2-ethyl-9,10-dimethoxyanthracene, 2-methyl- or 2-ethyl-9,10-diethoxyanthracene, 2-methyl- or 2-ethyl-9,10-dipropoxyanthracene, 2-methyl- or 2-ethyl-9,10-diisopropoxyanthracene, 2-methyl- or 2-ethyl-9,10-dibutoxyanthracene, 2-methyl- or 2-ethyl-9,10-dipentyloxyanthracene, 2-methyl- or 2-ethyl-9,10-dihexyloxyanthracene, and the like.
[0239] Examples of the naphthalene compounds include 4-methoxy-1-naphthol, 4-ethoxy-1-naphthol, 4-propoxy-1-naphthol, 4-butoxy-1-naphthol, 4-hexyloxy-1-naphthol, 1,4-dimethoxynaphthalene, 1-ethoxy-4-methoxynaphthalene, 1,4-diethoxynaphthalene, 1,4-dipropoxynaphthalene, and 1,4-dibutoxynaphthalene.
[0240] The curable composition of the present invention may contain 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, N-(2-aminoethyl)-3-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldiethoxysilane, N-(2-aminoethyl)- Aminosilane compounds such as 8-aminooctyltrimethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, 3-triethoxysilyl-N-(1,3-dimethylbutylidene)propylamine; mercaptosilane compounds such as 3-mercaptopropyltrimethoxysilane; 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane Silane coupling agents such as ethoxysilane, 3-glycidyloxypropyltriethoxysilane and other epoxysilane compounds, monoglycidyl ethers, dioctyl phthalate, dibutyl phthalate, benzyl alcohol, coal tar and other reactive or non-reactive diluents (plasticizers); glass fiber, carbon fiber, cellulose, silica sand, cement, kaolin, clay, aluminum hydroxide, bentonite, talc, silicon dioxide, micro powder silicon dioxide, titanium dioxide, carbon black, graphite, iron oxide, asphalt Fillers or pigments such as candelilla wax, carnauba wax, wood wax, insect wax, beeswax, lanolin, spermaceti, montan wax, petroleum wax, fatty acid wax, fatty acid ester, fatty acid ether, aromatic ester, aromatic ether and other lubricants; thickeners; thixotropic agents; antioxidants; light stabilizers; ultraviolet absorbers; flame retardants; defoamers; rust inhibitors; colloidal silica, colloidal alumina and other known additives, and further, adhesive resins such as xylene resins and petroleum resins can also be used in combination.
[0241] The curable composition of the present invention can be cured by light and / or heat by changing the type of the curing agent as the component (B) or using a plurality of types in combination.
[0242] Among them, the curable composition of the present invention can be suitably used as the photopolymerization initiator of (B) component and amine curing agent and the method of heat curing after temporary curing by light irradiation. In this case, if it contains many compounds with only epoxy groups and / or compounds with only reactive unsaturated bonds, sometimes curing is insufficient, or the physical properties of the cured product may be reduced. Therefore, the amount of the compound with only epoxy groups and / or the compound with only reactive unsaturated bonds is preferably less than 100 mass parts relative to 100 mass parts of the compound (A) component of the present invention, and more preferably less than 70 mass parts. In addition, the photopolymerization initiator is preferably a light free radical polymerization initiator.
[0243] D. Cured product and method for producing the cured product
[0244] The method for producing a cured product disclosed herein comprises a curing step of curing the curable composition. The curing method in the curing step is at least one of heating and light irradiation, and preferably both.
[0245] The light irradiated during photocuring can be set to include light with a wavelength of 300 nm to 450 nm. As the light source for photocuring, low-pressure mercury lamps, medium-pressure mercury lamps, high-pressure mercury lamps, ultra-high-pressure mercury lamps, xenon lamps, metal halide lamps, electron beam irradiation devices, X-ray irradiation devices, lasers (argon lasers, dye lasers, nitrogen lasers, LEDs, helium-cadmium lasers, etc.) can be listed.
[0246] The heating temperature in thermal curing can be appropriately set according to the type of the curing agent as long as it is a temperature at which the cured product can be stably cured, and is preferably set to 10°C to 250°C, and more preferably 60°C to 200°C.
[0247] From the aspect of excellent performance such as heat resistance, the cured product of the curable composition of the present invention is preferably a cured product obtained by heat curing after photocuring. The applicant believes that this record is a record indicating a state. Even if this record is a record of determining a substance by a manufacturing method, it is impossible and impractical to determine the structure and characteristics other than those recorded in this specification because a large amount of experimental time is required for the cured product obtained by curing the curable compound under prescribed conditions.
[0248] The curable composition of the present invention can be used in a wide range of applications such as coatings, adhesives, binders, coating agents, fiber bunching agents, building materials, electronic components, etc. In particular, due to its excellent curability using light and heat, it can be used for dual-curing applications. Due to these characteristics, the curable composition of the present invention can be suitably used for applications such as liquid sealants, liquid adhesives, liquid crystal sealants, and adhesives for camera modules.
[0249] E. Others [1]
[0251] A compound represented by the following general formula (1).
[0252] [Chemical formula 43]
[0253]
[0254] In the formula, R 1 represents a hydrogen atom or a methyl group, R 2each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 3 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group, a methylglycidyl ether group, an acryloyloxymethyl group or a methacryloyloxymethyl group, and R 4 represents a hydrogen atom or a methyl group. n represents a number of 0 to 4. [2]
[0256] A compound represented by the following general formula (2).
[0257] [Chemical formula 44]
[0258]
[0259] In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 5 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methylglycidyl ether group. n represents a number of 0 to 4. [3]
[0261] The method for producing the compound represented by the general formula (1) is characterized in that the compound represented by the general formula (3) is reacted with an epihalohydrin to produce the compound represented by the general formula (2), and the compound is esterified using an acrylic acid derivative and / or a methacrylic acid derivative.
[0262] [Chemical formula 45]
[0263]
[0264] In the formula, R 2 Each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent. 6 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or a hydroxymethyl group. n represents a number of 0 to 4. [4]
[0266] A curable material comprising a compound represented by the above general formula (1), and
[0267] At least one selected from the group consisting of the compound represented by the above general formula (2) and the compound represented by the following general formula (4).
[0268] [Chemical formula 46]
[0269]
[0270] In the formula, R 7 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms, a hydroxyl group or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a hydroxyl group or a halogen atom as a substituent, and R 8 R represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxyalkyl group, a glycidyl ether group, a methylglycidyl ether group, a glycidyloxyalkyl group, a β-methylglycidyloxyalkyl group, an acryloyloxyalkyl group or a methacryloyloxyalkyl group. 9 represents a hydrogen atom or a methyl group. m represents a number of 0-4. [5]
[0272] The curable material according to [4], comprising a compound represented by the general formula (4). [6]
[0274] A curable composition comprising (A) at least one of the compounds described in [1] and (B) at least one selected from curing agents. [7]
[0276] The curable composition according to [6] further comprises at least one of the compound represented by the general formula (2) and the compound represented by the general formula (4). [8]
[0278] A method for producing a cured product, comprising a curing step of curing the curable composition according to [6] or [7]. [9]
[0280] The method for producing a cured product according to [8], wherein the curing method in the curing step is at least one of heating and light irradiation.
[10]
[0282] A cured product, which is a cured product of the curable composition according to [6] or [7].
[0283] Example
[0284] Next, the present invention will be described in more detail by way of examples, but the present invention is not limited to these examples.
[0285] [Example 1] Preparation of DOP-EP (Compound represented by the following formula)
[0286] 238 g (1.0 mol) of DOP (a compound represented by the following formula) and 463 g (5.0 mol, 5.0 equivalents) of epichlorohydrin were added to a flask equipped with a reflux device, a stirring device, and a dropping device. 79 g (0.95 mol) of a 48% by mass sodium hydroxide aqueous solution was added dropwise thereto at 65-70°C and 21.0 kPa for 2 hours and 30 minutes. After the reaction was completed, the remaining epichlorohydrin was removed by vacuum distillation. Thereafter, 450 g (150% by mass) of toluene was added thereto, and the toluene was removed after washing with water three times to obtain a crude product.
[0287] Crude yield 277.35 g, crude yield 93.7%, epoxy equivalent 314 g / eq. (theoretical epoxy equivalent 294 g / eq.), saponifiable chlorine 4600 ppm
[0288] 266 g of the crude product was dissolved in 450 g (150 mass%) of toluene, and 4.7 g (50 mmol) of a 48 mass% aqueous sodium hydroxide solution was added dropwise, followed by reaction at 60° C. for 2 hours. The obtained reaction product was washed with water three times, and then toluene was removed to obtain the target product.
[0289] Yield: 277.35 g, yield: 93.7%, epoxy equivalent: 298 g / eq. (theoretical epoxy equivalent: 294 g / eq.), total chlorine: 1500 ppm by mass
[0290] The obtained compound (DOP-EP) was 1 - The results of NMR measurement are shown below. NMR was measured using ECX-400 manufactured by JEOL Ltd. Deuterated dimethyl sulfoxide (dDMSO) was used as a measurement solvent.
[0291] [Chemical formula 47]
[0292]
[0293] [Chemical formula 48]
[0294]
[0295] (The compound obtained in Example 1 1 H-NMR measurement results)
[0296] [Chemical formula 49]
[0297] DOP-EP
[0298] 1H-NMR (400MHz, DMSO-d6, 25°C): δ=7.32 (d, 2H, J=8.8Hz, a), 6.93 (d, 2H, J=9.2Hz, b), 5.35 (s, 1H, c ), 4.60 (t, 1H, J = 5.0Hz, d), 4.32 (dd, 1H, J = 11.2, 2.8Hz, e), 3.91 (d, 2H, J = 11.2Hz, f), 3.82 (dd, 1 H, J=11.6, 6.8Hz, g), 3.66 (d, 2H, J=4.8Hz, h), 3.56 (d, 2H, J=11.2Hz, i), 3.32 (m, 1H, j), 2.83 (t, 1H, J=5.2Hz, k), 2.70 (dd, 1H, J=5.2, 2.8Hz, 1), 1.14 (q, 2H, J=8.0Hz, m), 0.78 (t, 3H, J=7.6Hz, n).
[0299]
[0300] [Example 2] Preparation of DOP-EP-AC (compound represented by the following formula)
[0301] Into a flask equipped with a reflux device and a stirring device, 236 g (0.80 mol) of the compound DOP-EP obtained above and 310 g (3.6 mol, 4.5 equivalents) of methyl acrylate were added. 6.8 g (2.5 mol%) of tetrabutoxytitanium and 353 g (150 mass %) of toluene were further added, and the mixture was stirred at 81°C to 87°C for 11 hours while removing methanol to carry out esterification reaction. After adding water to the reaction product and stirring at 60°C for 1 hour, reflux dehydration was carried out at 60°C and 20 Pa, and toluene was removed after filtration to obtain the target product (hereinafter referred to as DOP-EP-AC).
[0302] Yield: 238.5 g, yield: 93.7%, epoxy equivalent: 369 g / eq. (theoretical epoxy equivalent: 348 g / eq.), total chlorine: 770 ppm by mass, Ti atom content: 1.3 ppm by mass
[0303] The obtained compound DOP-EP-AC was 1 -NMR measurement results are shown below. NMR ECX-NMR manufactured by JEOL Ltd. Measurement was performed using ECX-400 manufactured by JEOL Ltd. Deuterated dimethyl sulfoxide (dDMSO) was used as a measurement solvent.
[0304] [Chemical formula 50]
[0305]
[0306] (The compound obtained in Example 21 H-NMR measurement results)
[0307] [Chemical formula 51]
[0308] DOP-EP-AC
[0309] 1 H-NMR (400MHz, DMSO-d6, 25°C): δ=7.33 (d, 2H, J=8.8Hz, a), 6.94 (d, 2H, J=8.8Hz, b), 6.36 (dd, 1H, J=17.2, 1.6 Hz, c), 6.25-6.18 (m, 1H, d), 5.97 (dd, 1H, J=10.0, 1.6Hz, e), 5.43 (s, 1H, f), 4.41 (s, 2H, g), 4.32 (dd, 1H, J=11 .6, 2.8Hz, h), 3.97 (d, 2H, J=12.0Hz, i), 3.82 (dd, 1H, J=11.4, 6.8Hz, j), 3.70 (d, 2H, J=12Hz, k), 3.31 (m, 1H, 1), 2.83 (t, 1H, J=5.2Hz, m), 2.70 (dd, 1H, J=5.2, 2.8Hz, n), 1.22 (q, 2H, J=7.6Hz, o), 0.80 (t, 3H, J=7.2Hz, p).
[0310]
[0311] [Example 3]
[0312] 100 parts by mass of DOP-EP-AC obtained in Example 2 above, 3 parts by mass of Irgacure 184 (manufactured by BASF; 1-hydroxycyclohexane-1-yl phenyl ketone) and 3 parts by mass of 2-ethyl-4-methylimidazole were mixed with a planetary stirring device to prepare a curable composition. The curable composition prepared above was applied to a glass plate with a thickness of 300 μm by a rod coater to obtain a coating film. The obtained curable composition was subjected to photocuring under the following conditions, or photocuring and heat curing were sequentially performed, and the dynamic viscoelasticity test of the cured product was performed under the following conditions. The results are shown in Figure 1 It should be noted that it was confirmed that curing sufficiently proceeded in the stage after light irradiation and before thermal curing to form a releasable coating film.
[0313] Light curing: UV light was irradiated for 2.0 seconds at 0.5 W using HOYA LED-UV irradiator LS series.
[0314] Thermal curing: Heating in a heat circulation oven at 150° C. for 2 hours.
[0315] Dynamic viscoelasticity test: The glass transition temperature (Tg) was measured using RSA manufactured by TA Instruments. As a test piece, a strip-shaped test piece having a width of 4 mm×a length of 60 mm×a thickness of 300 μm was prepared.
[0316] [Example 4] Preparation of DOP2-EP (Compound represented by the following formula)
[0317] Into a flask equipped with a reflux device, a stirring device and a dropping device, 160 g (0.67 mole) of DOP2 (a compound represented by the following formula) and 496 g (5.4 moles, 8.0 equivalents) of epichlorohydrin were added. 53.3 g (0.64 mole) of a 48% by mass aqueous sodium hydroxide solution was added dropwise at 65-70°C and 18.0 kPa for 2 hours and 30 minutes. After the reaction was completed, the remaining epichlorohydrin was removed by vacuum distillation. Thereafter, 298 g (150% by mass) of toluene was added thereto, and the toluene was removed after washing with water three times to obtain a crude product.
[0318] Crude yield 181.2 g, crude yield 91.7%, epoxy equivalent 316 g / eq. (theoretical epoxy equivalent 294 g / eq.), saponifiable chlorine 3400 ppm
[0319] 166 g of the crude product was dissolved in 332 g (200 mass%) of toluene, and 2.0 g (24 mmol) of a 48 mass% aqueous sodium hydroxide solution was added dropwise, followed by reaction at 60° C. for 2 hours. The reaction product was washed with water three times, and then toluene was removed to obtain the target product.
[0320] Yield 159.9 g, yield 96.3%, epoxy equivalent 324 g / eq. (theoretical epoxy equivalent 294 g / eq.), total chlorine 736 ppm
[0321] The obtained compound (DOP2-EP) was 1 - The results of NMR measurement are shown below. NMR was measured using ECX-400 manufactured by JEOL Ltd. Deuterated dimethyl sulfoxide (dDMSO) was used as a measurement solvent.
[0322] [Chemical formula 52]
[0323]
[0324] [Chemical formula 53]
[0325]
[0326] (The compound obtained in Example 4 1 H-NMR measurement results)
[0327] [Chemical formula 54]
[0328] DOP2-EP
[0329] 1 H-NMR (400MHz, DMSO-d6, 25°C): δ=7.46 (dd, 1H, J=7.2, 1.6Hz, a), 7.33-7.29 (m, 1H, b), 7.11-6. 95 (m, 2H, c), 5.69-5.67 (m, 1H, d), 4.62 (t, 1H, J=5.6Hz, e), 4.34 (dd, 1H, J=11.4, 2.0Hz, f), 3.9 2-3.87 (m, 3H, g), 3.71 (d, 2H, J = 4.8Hz, h), 3.56 (d, 2H, J = 11.2Hz, i), 3.34 (m, 1H, j), 2.85 (t, 1H , J=5.2Hz, k), 2.73 (dd, 1H, J=5.2, 2.8Hz, 1), 1.15 (q, 2H, J=7.6Hz, m), 0.78 (t, 3H, J=7.6Hz, n).
[0330]
[0331] [Example 5] Preparation of DOP2-EP-AC (Compound represented by the following formula)
[0332] Into a flask equipped with a reflux device and a stirring device, 130 g (0.44 mol) of the compound DOP2-EP obtained above and 148 g (1.7 mol, 3.9 equivalents) of methyl acrylate were added. 3.8 g (2.5 mol%) of tetrabutoxytitanium and 195 g (150 mass %) of toluene were further added, and the methanol removal reaction was carried out while stirring at 81°C to 87°C for 21 hours. After adding water to the obtained reaction product and stirring at 60°C for 1 hour, reflux dehydration was carried out at 60°C and 20 Pa, and toluene was removed after filtration to obtain the target product (hereinafter referred to as DOP2-EP-AC).
[0333] Yield 133.3 g, yield 86.6%, epoxy equivalent 395 g / eq. (theoretical epoxy equivalent 348 g / eq.), total chlorine 604 mass ppm, Ti atom content 22.0 mass ppm
[0334] The obtained compound DOP2-EP-AC was 1 -NMR measurement results are shown below. NMR was measured using ECX-400 manufactured by JEOL Ltd. Deuterated dimethyl sulfoxide (DMSO) was used as a measurement solvent.
[0335] [Chemical formula 55]
[0336]
[0337] (The compound obtained in Example 5 1 H-NMR measurement results)
[0338] [Chemical formula 56]
[0339] DOP EP-AC
[0340] 1 H-NMR (400MHz, DMSO-d6, 25°C): δ=7.46 (dd, 1H, J=7.8, 2.0Hz, a), 7.34-7.30 (m, 1H, b), 7.03-6.96 (m, 2H, c), 6.37 (dd , 1H, J=17.4, 1.6Hz, d), 6.256.18 (m, 1II, e), 5.97 (dd, 1II, J=10.4, 1.6IIz, f), 5.75 (s, 1H, g), 4.45 (s, 2H, h), 4.34 (dd, 1H, J=11.6, 2.8Hz, i), 3.97 (d, 2H, J=11.6Hz, j), 3.90 (dd, 1II, J=11.8, 6.4IIz, k), 3.70 (d, 2II, J=12Hz, 1), 3. 33 (m, 1H, m), 2.85 (t, 1H, J-4.8Hz, n), 2.74 (dd, 1H, J-5.2, 2.4Hz, o), 1.24 (q, 2H, J-7.2Hz, p), 0.80 (t, 3H, J=8Hz, q).
[0341]
[0342] [Example 6]
[0343] 100 parts by mass of DOP2-EP-AC obtained in Example 5 above, 3 parts by mass of Irgacure 184 (manufactured by BASF; 1-hydroxycyclohexane-1-yl phenyl ketone) and 3 parts by mass of 2-ethyl-4-methylimidazole were mixed with a planetary stirring device to prepare a curable composition. The curable composition prepared above was applied to a glass plate with a thickness of 300 μm by a rod coater to obtain a coating film. The obtained curable composition was subjected to photocuring and heat curing in sequence under the following conditions, and the dynamic viscoelasticity test of the cured product was conducted under the following conditions. The results are shown in Figure 2 (The result of UV curing was not measured). It was confirmed that curing sufficiently proceeded in the stage after light irradiation and before heat curing to form a releasable coating film.
[0344] Light curing: UV light was irradiated for 2.0 seconds at 0.5 W using HOYA LED-UV irradiator LS series.
[0345] Thermal curing: Heating in a heat circulation oven at 150° C. for 2 hours.
[0346] DMA (dynamic viscoelasticity measurement): The glass transition temperature (Tg) was measured using RSA manufactured by TA Instruments. As a test piece, a strip-shaped test piece having a width of 5 mm×a length of 60 mm×a thickness of 300 μm was prepared.
[0347] As mentioned above, if Figure 1 It was confirmed that the compound obtained in Example 2 had sufficient photocurability and excellent thermosetting property. In addition, as mentioned above, the compound obtained in Example 5 also had sufficient photocurability. In addition, the photo- and thermosetting materials using the compound obtained in Example 5 were Figure 2 Thus, there is no significant decrease in storage modulus E' before exceeding the heat curing temperature of 150°C, showing a certain curability. In addition, it is also found that the light and heat cured product using the compound of Example 5 has a high glass transition temperature of 183°C and heat resistance. As such, the compound provided by the present invention can provide a curable composition with excellent curability using light and heat.
[0348] [Example 7] Preparation of DOP2-EP / DOP2-EP-AC mixture
[0349] Into a flask equipped with a reflux device and a stirring device, 130 g (0.44 mol) of the compound DOP2-EP obtained above and 148 g (1.7 mol, 3.9 equivalents) of methyl acrylate were added. 3.8 g (2.5 mol%) of tetrabutoxytitanium and 195 g (150 mass %) of toluene were further added, and the demethanolation reaction was carried out while stirring at 81°C to 87°C for 12 hours. After adding water to the obtained reaction product and stirring at 60°C for 1 hour, reflux dehydration was carried out at 60°C and 20 Pa, and toluene was removed after filtering to obtain a curable material 1. Analysis by gas chromatography confirmed that the curable material 1 was a mixture of DOP2-EP and DOP2-EP-AC, and the mass ratio (DOP2-EP: DOP2-EP-AC) was 5:95.
[0350] [Example 8] Preparation of a mixture of DOP2-EP / DOP2-EP2 (compound represented by the following formula)
[0351] 160 g (0.67 mol) of DOP2 and 496 g (5.4 mol, 8.0 equivalents) of epichlorohydrin were added to a flask equipped with a reflux device, a stirring device and a dropping device. 53.3 g (0.70 mol) of a 48% by mass sodium hydroxide aqueous solution was added dropwise thereto at 65-70°C and 18.0 kPa for 2 hours and 30 minutes. After the reaction was completed, the remaining epichlorohydrin was removed by vacuum distillation. Thereafter, 298 g (150% by mass) of toluene was added thereto, and the toluene was removed after washing with water three times to obtain a curable material 2. The result of the analysis by gas chromatography confirmed that the curable material 2 was a mixture of DOP2-EP and DOP2-EP2, and the mass ratio (DOP2-EP: DOP2-EP2) was 97:3.
[0352] [Chemical formula 57]
[0353]
[0354] [Example 9] Preparation of DOP2-EP / DOP2-EP2 / DOP2-EP-AC mixture
[0355] 130 g (0.44 mol) of the curable material 2 obtained above and 148 g (1.7 mol, 3.9 equivalents) of methyl acrylate were added to a flask equipped with a reflux device and a stirring device. 3.8 g (2.5 mol%) of tetrabutoxytitanium and 195 g (150 mass %) of toluene were further added, and the demethanolation reaction was carried out while stirring at 81°C to 87°C for 12 hours. Water was added to the obtained reaction product and stirred at 60°C for 1 hour, and then refluxed and dehydrated at 60°C and 20 Pa. After filtering, toluene was removed to obtain curable material 3. Analysis by gas chromatography confirmed that the curable material 3 was a mixture of DOP2-EP, DOP2-EP-AC, and DOP2-EP-AC, and the mass ratio (DOP2-EP: DOP2-EP2: DOP2-EP-AC) was 5:3:92.
[0356] 100 parts by mass of the curable material 1 obtained in Example 7 or the curable material 3 obtained in Example 9, 3 parts by mass of Irgacure 184 (manufactured by BASF; 1-hydroxycyclohexane-1-yl phenyl ketone) and 3 parts by mass of 2-ethyl-4-methylimidazole were kneaded with a planetary stirring device to prepare a curable composition. The curable composition prepared above was applied to a glass plate with a thickness of 300 μm by a bar coater to obtain a coating film. The obtained curable composition was subjected to photocuring and heat curing in sequence according to the following conditions, and the presence or absence of curing was confirmed according to the following evaluation criteria (A, B).
[0357] Light curing: UV light was irradiated for 2.0 seconds at 0.5 W using HOYA LED-UV irradiator LS series.
[0358] (Evaluation criteria for photocurability)
[0359] A: It was confirmed that curing sufficiently proceeded after photocuring and before heat curing, and a releasable coating film was formed.
[0360] B: Insufficient curing was observed after photocuring and before heat curing, and a releasable coating film was not formed.
[0361] Thermal curing: Heating in a heat circulation oven at 150° C. for 2 hours.
[0362] (Evaluation criteria for thermosetting properties)
[0363] A: It was confirmed that curing sufficiently proceeded after thermal curing, and a releasable coating film was formed.
[0364] B: Insufficient curing was confirmed after thermal curing. The curing was insufficient and a coating film capable of being released from the mold was not formed.
[0365] Table 1
[0366]
[0367] As described above, it was confirmed that the curable composition including the mixture containing the compound of formula (1) and the compound of formula (2) and / or the compound of formula (4) also has sufficient photocurability and thermosetting property.
[0368] Industrial Applicability
[0369] The compound of the present invention can be cured by light and heat, and a curable composition containing the compound has excellent curability by light and heat, and can be used for applications such as liquid sealants, liquid adhesives, adhesives for camera modules, and liquid crystal sealants.
Claims
1. A compound represented by the following general formula (1): In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 3 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group, a methylglycidyl ether group, an acryloyloxymethyl group or a methacryloyloxymethyl group, and R 4 represents a hydrogen atom or a methyl group, and n represents a number of 0-4.
2. A compound represented by the following general formula (2): In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 5 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methylglycidyl ether group, and n represents a number of 0 to 4.
3. A method for producing a compound represented by the following general formula (1), characterized in that: The compound represented by the following general formula (3) is reacted with epihalohydrin to produce a compound represented by the following general formula (2), and the compound is esterified with an acrylic acid derivative and / or a methacrylic acid derivative. In the formula, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, and R 6 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or a hydroxymethyl group, and n represents a number from 0 to 4; In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 5 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methylglycidyl ether group, and n represents a number from 0 to 4; In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 3 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group, a methylglycidyl ether group, an acryloyloxymethyl group or a methacryloyloxymethyl group, and R 4 represents a hydrogen atom or a methyl group, and n represents a number of 0-4.
4. A curable material comprising a compound represented by the following general formula (1), and At least one selected from the group consisting of a compound represented by the following general formula (2) and a compound represented by the following general formula (4), In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, R 3 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group, a methylglycidyl ether group, an acryloyloxymethyl group or a methacryloyloxymethyl group, and R 4 represents a hydrogen atom or a methyl group, and n represents a number from 0 to 4; In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, and R 5 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methylglycidyl ether group, and n represents a number from 0 to 4; In the formula, R 7 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms, a hydroxyl group or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a hydroxyl group or a halogen atom as a substituent, and R 8 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxyalkyl group, a glycidyl ether group, a methylglycidyl ether group, a glycidyloxyalkyl group, a β-methylglycidyloxyalkyl group, an acryloyloxyalkyl group or a methacryloyloxyalkyl group, and R 9 represents a hydrogen atom or a methyl group, and m represents a number of 0-4.
5. The curable material according to claim 4, wherein Contains a compound represented by the general formula (4). 6 . A curable composition comprising (A) at least one of the compounds according to claim 1 and (B) at least one selected from curing agents.
7. The curable composition according to claim 6, wherein further contains at least one of a compound represented by the following general formula (2) and a compound represented by the following general formula (4), In the formula, R 1 represents a hydrogen atom or a methyl group, R 2 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms or a halogen atom as a substituent, and R 5 represents an alkyl group having 1 to 10 carbon atoms, a hydroxymethyl group, a glycidyl ether group or a methyl glycidyl ether group, and n represents a number from 0 to 4; In the formula, R 7 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 5 to 10 carbon atoms, a hydroxyl group or a halogen atom which may have an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a hydroxyl group or a halogen atom as a substituent, and R 8 represents a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, a hydroxyalkyl group, a glycidyl ether group, a methylglycidyl ether group, a glycidyloxyalkyl group, a β-methylglycidyloxyalkyl group, an acryloyloxyalkyl group or a methacryloyloxyalkyl group, and R 9 represents a hydrogen atom or a methyl group, and m represents a number of 0-4. 8 . A method for producing a cured product, comprising a curing step of curing the curable composition according to claim 6 or claim 7.
9. The method for producing a cured product according to claim 8, wherein: The curing method in the curing step is at least one of heating and light irradiation. 10 . A cured product, which is a cured product of the curable composition according to claim 6 or 7 .
Citation Information
Patent Citations
Process for preventing polymer buildup in a polymerization reactor
EP0000400A1
Process for preparing butyl-p-benzoylbenzoates
EP0000502A1
Photo and heat curable composition, and cured product using the same
JP2009051954A
Epoxy-(METH)acrylate monomers and polymers and methods of making and using the same
US20200048301A1
Curable composition and structure
WO2018181421A1
